drugset / Trial / NCT02769793

Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON

NCT02769793

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether levodopa/benserazide dispersible is effective in the adjunctive treatment of Parkinson's disease (PD) patients with delayed ON.

Timeline

Start
2015-06
Primary completion
2018-08
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule 100 mg Oral

Indications